FrancophonIA/ELRC3.0 huggingface dataset:
English: Tobi Podhaler was more effective than placebo in treating P. aeruginosa infection in patients with cystic fibrosis.
Danish: Tobi Podhaler havde større virkning end placebo til behandling af infektion med P. aeruginosa hos patienter med cystisk fibrose.
English: Tobi Podhaler was studied in two main trials in patients who had cystic fibrosis with P. aeruginosa lung infection.
Danish: Tobi Podhaler blev undersøgt i to hovedundersøgelser, som omfattede patienter med cystisk fibrose og lungeinfektion med P. aeruginosa.
English: Why has Tobi Podhaler been approved?
Danish: Hvorfor blev Tobi Podhaler godkendt?
English: For more information on how to use Tobi Podhaler, see the instructions in the package leaflet.
Danish: Yderligere oplysninger om anvendelsen af Tobi Podhaler fremgår af indlægssedlen.
English: Cystic fibrosis is an inherited disease in which there is accumulation of thick mucus in the lungs that allows bacteria to grow more easily causing infections.
Danish: Cystisk fibrose er en arvelig sygdom, der giver ophobning af tyk slim i lungerne.
English: What is Tobi Podhaler?
Danish: Hvad er Tobi Podhaler?
English: The full EPAR for Tobi Podhaler can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Tobi Podhaler findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports De nærmere oplysninger om behandling med Tobi Podhaler fremgår af indlægssedlen (også en del af EPAR), eller du kan kontakte din læge eller dit apotek.
English: How has Tobi Podhaler been studied?
Danish: Hvordan blev Tobi Podhaler undersøgt?
English: What is Tobi Podhaler used for?
Danish: Hvad anvendes Tobi Podhaler til?
English: Tobi Podhaler is used to suppress chronic lung infection caused by bacteria called Pseudomonas aeruginosa in adults and children aged 6 years and over who have cystic fibrosis.
Danish: Tobi Podhaler anvendes til behandling af patienter fra seks år og opefter med cystisk fibrose for kroniske lungeinfektioner forårsaget af bakterien Pseudomonas aeruginosa.
English: How is Tobi Podhaler used?
Danish: Hvordan anvendes Tobi Podhaler?
English: What benefit has Tobi Podhaler shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Tobi Podhaler?
English: Emtricitabine/Tenofovir disoproxil Mylan received a marketing authorisation valid throughout the EU on 16 December 2016.
Danish: Emtricitabine/Tenofovir disoproxil Mylan fik en markedsføringstilladelse med gyldighed i hele EU den 16. december 2016.
English: In addition, it may be used in adolescents with HIV who are resistant to first-line treatments or who cannot take them because of side effects.
Danish: Desuden kan det anvendes hos unge med hiv, som er resistente over for førstevalgsbehandlingerne, eller som ikke kan tage dem på grund af bivirkninger.
English: Further information on Emtricitabine/Tenofovir disoproxil Mylan can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/emtricitabinetenofovir-disoproxil-mylan.
Danish: Yderligere information vedrørende Emtricitabine/Tenofovir disoproxil Mylan findes på agenturets websted under: ema.europa.eu/medicines/human/EPAR/emtricitabinetenofovir-disoproxil-mylan.
English: The European Medicines Agency concluded that, in accordance with EU requirements, Emtricitabine/Tenofovir disoproxil Mylan has been shown to have comparable quality and to be bioequivalent to Truvada.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at det i overensstemmelse med EU's krav er påvist, at Emtricitabine/Tenofovir disoproxil Mylan er af sammenlignelig kvalitet og er bioækvivalent med Truvada.
English: Side effects reported with Emtricitabine/Tenofovir disoproxil Mylan are carefully evaluated and any necessary action taken to protect patients.
Danish: Bivirkninger rapporteret for Emtricitabine/Tenofovir disoproxil Mylan vurderes omhyggeligt, og der tages de nødvendige forholdsregler for at beskytte patienterne.
English: Because Emtricitabine/Tenofovir disoproxil Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Danish: Da Emtricitabine/Tenofovir disoproxil Mylan er et generisk lægemiddel og er bioækvivalent med referencelægemidlet, anses dets fordele og risici for at være de samme som for referencelægemidlet.
English: Studies on the benefits and risks of the active substances in the authorised uses have already been carried out with the reference medicine, Truvada, and do not need to be repeated for Emtricitabine/Tenofovir disoproxil Mylan.
Danish: Der er allerede foretaget studier af de aktive stoffers fordele og risici ved godkendt brug med referencelægemidlet, Truvada, og de behøver ikke blive gentaget for Emtricitabine/Tenofovir disoproxil Mylan.
English: Both emtricitabine and tenofovir work in similar ways by blocking the activity of reverse transcriptase, an enzyme produced by HIV that allows it to reproduce itself in the cells it has infected.
Danish: Emtricitabin og tenofovir ligner hinanden, idet de begge blokerer aktiviteten af revers transkriptase, et enzym, der produceres af hiv, og som gør det muligt for virusset at reproducere sig selv i de celler, det har inficeret.
English: For more information about using Emtricitabine/Tenofovir disoproxil Mylan, see the package leaflet or contact your doctor or pharmacist.
Danish: For mere information om brug af Emtricitabine/Tenofovir disoproxil Mylan, se indlægssedlen eller kontakt lægen eller apotekspersonalet.
English: Emtricitabine/Tenofovir disoproxil Mylan does not cure HIV infection or AIDS, but it holds off damage to the immune system and the development of infections and diseases associated with AIDS.
Danish: Emtricitabine/Tenofovir disoproxil Mylan helbreder ikke hivinfektion eller aids, men udsætter den skade på immunsystemet og de infektioner og sygdomme, der er forbundet med aids.
English: Emtricitabine/Tenofovir disoproxil Mylan can only be obtained with a prescription and treatment should be started by a doctor who has experience in the management of HIV infection.
Danish: Emtricitabine/Tenofovir disoproxil Mylan udleveres kun efter recept, og behandlingen bør iværksættes af en læge med erfaring i behandling af hivinfektion.
English: Emtricitabine/Tenofovir disoproxil Mylan is also used to help prevent sexually transmitted HIV-1 infection in adults and adolescents who are at high risk of being infected (pre-exposure prophylaxis or PrEP).
Danish: Emtricitabine/Tenofovir disoproxil Mylan anvendes også til forebyggelse af seksuelt overført hiv-1infektion hos voksne og unge, som har høj risiko for at blive smittet (profylakse før eksponering eller PrEP).
English: Healthcare professionals will also receive a brochure and reminder card to hand out to individuals receiving the medicine for preexposure prophylaxis.
Danish: Sundhedspersoner vil også modtage en brochure og et huskekort til uddeling til personer, der tager lægemidlet som profylakse før eksponering.
English: Emtricitabine/Tenofovir disoproxil Mylan is an HIV medicine that is used in combination with at least one other HIV medicine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Danish: Emtricitabine/Tenofovir disoproxil Mylan er et hivlægemiddel, der anvendes sammen med mindst ét andet hivlægemiddel til behandling af voksne, som er smittet med humant immundefektvirus type 1 (hiv-1), dvs. det virus, som er årsag til erhvervet immundefektsyndrom (aids).
English: As for every medicine, the company provided studies on the quality of Emtricitabine/Tenofovir disoproxil Mylan.
Danish: Som for alle lægemidler har virksomheden leveret studier af kvaliteten af Emtricitabine/Tenofovir disoproxil Mylan.
English: For pre-exposure prophylaxis of HIV-1 infection, it is expected that Emtricitabine/Tenofovir disoproxil Mylan in the blood will stop the virus from multiplying and spreading from the site of infection in case the individual is exposed to the virus.
Danish: Ved profylakse før eksponering for hiv-1-infektion forventes Emtricitabine/Tenofovir disoproxil Mylan i blodet at forhindre virusset i at formere og sprede sig fra infektionsstedet, hvis personen eksponeres for virusset.
English: The company that markets Emtricitabine/Tenofovir disoproxil Mylan will provide an information pack to doctors which covers the potential harmful effects of Emtricitabine/Tenofovir disoproxil Mylan on kidney function and information about use for pre-exposure prophylaxis.
Danish: Virksomheden, der markedsfører Emtricitabine/Tenofovir disoproxil Mylan, vil forsyne lægerne med en informationspakke, som omhandler de mulige skadelige virkninger af Emtricitabine/Tenofovir disoproxil Mylan på nyrefunktionen samt information om brug i forbindelse med profylakse før eksponering.
English: As for all medicines, data on the use of Emtricitabine/Tenofovir disoproxil Mylan are continuously monitored.
Danish: Som for alle lægemidler er data vedrørende brug af Emtricitabine/Tenofovir disoproxil Mylan løbende overvåget.
English: Therefore, the Agency's view was that, as for Truvada, the benefit of Emtricitabine/Tenofovir disoproxil Mylan outweighs the identified risk and it can be authorised for use in the EU.
Danish: Det var derfor agenturets opfattelse, at fordelene ved Emtricitabine/Tenofovir disoproxil Mylan opvejer de identificerede risici, som for Truvada, og at det kan godkendes til anvendelse i EU.
English: An overview of Emtricitabine/Tenofovir disoproxil Mylan and why it is authorised in the EU
Danish: Oversigt over Emtricitabine/Tenofovir disoproxil Mylan, og hvorfor det er godkendt i EU
English: Emtricitabine/Tenofovir disoproxil Mylan is available as tablets (200 mg emtricitabine and 245 mg tenofovir disoproxil).
Danish: Emtricitabine/Tenofovir disoproxil Mylan fås som tabletter (200 mg emtricitabin og 245 mg tenofovirdisoproxil).
English: What measures are being taken to ensure the safe and effective use of Emtricitabine/Tenofovir disoproxil Mylan?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Emtricitabine/Tenofovir disoproxil Mylan?
English: Other information about Emtricitabine/Tenofovir disoproxil Mylan
Danish: Andre oplysninger om Emtricitabine/Tenofovir disoproxil Mylan
English: Emtricitabine/Tenofovir disoproxil Mylan contains two active substances: emtricitabine, which is a nucleoside reverse transcriptase inhibitor; and tenofovir disoproxil, which is a ‘prodrug' of tenofovir.
Danish: Emtricitabine/Tenofovir disoproxil Mylan indeholder følgende to aktive stoffer: emtricitabin, der er en nukleosidrevers transkriptasehæmmer, og tenofovirdisoproxil, der er et "prodrug" til tenofovir.
English: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabine / tenofovir disoproxil)
Danish: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabin/tenofovirdisoproxil)
English: What is Emtricitabine/Tenofovir disoproxil Mylan and what is it used for?
Danish: Hvad er Emtricitabine/Tenofovir disoproxil Mylan, og hvad anvendes det til?
English: Emtricitabine/Tenofovir disoproxil Mylan contains two active substances, emtricitabine and tenofovir disoproxil.
Danish: Emtricitabine/Tenofovir disoproxil Mylan indeholder de to aktive stoffer emtricitabin og tenofovirdisoproxil.
English: What are the benefits and risks of Emtricitabine/Tenofovir disoproxil Mylan?
Danish: Hvilke fordele og risici er der forbundet med Emtricitabine/Tenofovir disoproxil Mylan?
English: Why is Emtricitabine/Tenofovir disoproxil Mylan authorised in the EU?
Danish: Hvorfor er Emtricitabine/Tenofovir disoproxil Mylan godkendt i EU?
English: For the treatment of HIV-infection, Emtricitabine/Tenofovir disoproxil Mylan, taken in combination with at least one other HIV medicine, reduces the amount of HIV in the blood and keeps it at a low level.
Danish: Ved behandling af hivinfektion nedsætter Emtricitabine/Tenofovir disoproxil Mylan hivmængden i blodet og holder den nede, når det anvendes i kombination med mindst ét andet hivlægemiddel.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Emtricitabine/Tenofovir disoproxil Mylan have also been included in the summary of product characteristics and the package leaflet.
Danish: Der er desuden anført anbefalinger og forholdsregler i produktresuméet og indlægssedlen, som patienter og sundhedspersonale skal følge for at sikre risikofri og effektiv anvendelse af Emtricitabine/Tenofovir disoproxil Mylan.
English: How has Emtricitabine/Tenofovir disoproxil Mylan been studied?
Danish: Hvordan blev Emtricitabine/Tenofovir disoproxil Mylan undersøgt?
English: How is Emtricitabine/Tenofovir disoproxil Mylan used?
Danish: Hvordan anvendes Emtricitabine/Tenofovir disoproxil Mylan?
English: How does Emtricitabine/Tenofovir disoproxil Mylan work?
Danish: Hvordan virker Emtricitabine/Tenofovir disoproxil Mylan?
English: Date of first authorisation: 15 July 1998 Date of latest renewal: 15 July 2008
Danish: Dato for første tilladelse: 15. juli 1998 Dato for første fornyelse: 15. juli 2008
English: Some other medicines may influence the use of Iscover or vice versa.
Danish: Visse andre lægemidler kan påvirke brugen af Iscover eller omvendt.
English: The other ingredients are (see section 2 ‘Iscover contains lactose' and ‘Iscover contains hydrogenated castor oil'):
Danish: De øvrige indholdsstoffer er (se afsnit 2 ”Iscover indeholder lactose” og ”Iscover indeholder hydrogeneret ricinusolie”):
English: Cmax occurs approximately 30 to 60 minutes after dosing.
Danish: Cmax opnås ca. 30-60 minutter after administration.
English: However, due to the lack of interaction studies with other NSAIDs it is presently unclear whether there is an increased risk of gastrointestinal bleeding with all NSAIDs.
Danish: Imidlertid er det på grund af manglen på interaktionsstudie med andre NSAID'er ikke umiddelbart klart, om der er øget risiko for gastrointestinal blødning med alle NSAID-præparater.
English: 67019 Scoppito (AQ) - Italy
Danish: 67019 Scoppito (AQ) - Italien
English: Strada Statale 17, Km 22 67019 Scoppito (AQ) - Italy
Danish: Strada Statale 17, Km 22 67019 Scoppito (AQ) - Italien
English: You should take Iscover for as long as your doctor continues to prescribe it.
Danish: Du skal fortsætte med at tage Iscover, så længe din læge udskriver det til dig.
English: For the 7, 14, 28 and 84 tablets pack sizes, you can check the day on which you last took a tablet of Iscover by referring to the calendar printed on the blister.
Danish: For pakninger med 7, 14, 28 og 84 stk. tabletter kan du tjekke på hvilken dag, du sidst tog en tablet ved at se på kalenderen trykt på blisterpakningen.
English: • Your doctor may order blood tests.
Danish: Kan din læge bede om blodprøver
English: Therefore, the guided de-escalation arm had patients on either prasugrel (40%) or clopidogrel (60%).
Danish: Derfor havde den guidede de-eskaleringsarm patienter behandlet med enten prasugrel (40%) eller clopidogrel (60%).
English: If you forget to take Iscover
Danish: Hvis du har glemt at tage Iscover
English: The clinically relevant adverse reactions observed in the CAPRIE, CURE, CLARITY, COMMIT and ACTIVE-A studies are discussed below.
Danish: De klinisk relevante bivirkninger observeret i CAPRIE-, CURE-, CLARITY, COMMIT og ACTIVE-Astudierne beskrives nedenfor.
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Danish: Hvis du ønsker yderligere oplysninger om Iscover, skal du henvende dig til den lokale repræsentant for indehaveren af markedsføringstilladelsen:
English: As a precautionary measure, breast-feeding should not be continued during treatment with Iscover.
Danish: Som forholdsregel bør amning ophøre under behandling med Iscover.
English: You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Iscover and acetylsalicylic acid for this condition.
Danish: Du bør være blevet informeret om, at ”orale antikoagulantia” er mere effektive mod denne sygdom end acetylsalicylsyre eller kombinationen af Iscover og acetylsalicylsyre.
English: Iscover contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products.
Danish: Iscover indeholder clopidogrel og tilhører en lægemiddelgruppe, der kaldes blodfortyndende medicin.
English: As no clinical data on exposure to clopidogrel during pregnancy are available, it is preferable not to use clopidogrel during pregnancy as a precautionary measure.
Danish: Graviditet Da der ikke foreligger kliniske data om eksponering for clopidogrel under graviditet, foretrækkes det, at clopidogrel ikke anvendes under graviditet af sikkerhedsmæssige årsager.
English: This leaflet was last revised in <Month YYYY>.
Danish: Denne indlægsseddel blev senest ændret <måned /ÅÅÅÅ>
English: Other medicines and Iscover:
Danish: Brug af anden medicin sammen med Iscover:
English: If you forget to take a dose of Iscover, but remember within 12 hours of your usual time, take your tablet straightaway and then take your next tablet at the usual time.
Danish: Hvis du glemmer at tage en dosis Iscover til sædvanlig tid, men kommer i tanke om det i løbet af 12 timer, skal du omgående tage tabletten og dernæst tage den næste tablet til sædvanlig tid.
English: If you become pregnant while taking Iscover, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Danish: Hvis du bliver gravid, mens du tager Iscover, skal du omgående kontakte din læge, da det frarådes at tage Iscover under graviditet.
English: Iscover contains lactose.
Danish: Iscover indeholder lactose.
English: Week 2 (for boxes of 14, 28 and 84 tablets) Week 3 (for boxes of 28 and 84 tablets) Week 4 (for boxes of 28 and 84 tablets)
Danish: Uge 2 For pakninger med 7, 28 og 84 tabletter Uge 3 For pakninger med 28 og 84 tabletter Uge 4 For pakninger med 28 og 84 tabletter
English: Your doctor should have prescribed Iscover plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding.
Danish: Din læge bør have udskrevet Iscover plus acetylsalicylsyre, hvis du ikke må tage ”orale antikoagulantia” og du ikke har en risiko for alvorlig blødning.
English: If Iscover is supplied in all aluminium blisters, it does not require any special storage conditions.
Danish: Hvis Iscover er pakket i blisterkort af ren aluminium kræves ingen særlige forholdsregler vedrørende opbevaringen.
English: If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Iscover.
Danish: Hvis du mener, at ovenstående gælder for dig, eller hvis du overhovedet er i tvivl, så rådfør dig med din læge, inden du tager Iscover.
English: Iscover is unlikely to affect your ability to drive or to use machines.
Danish: Trafik og arbejdssikkerhed Det er usandsynligt, at Iscover vil påvirke din evne til at køre eller betjene maskiner.
English: The clinical benefit provided by the more potent P2Y12 inhibitors, ticagrelor and prasugrel, in their pivotal studies is related to a significant reduction in recurrent ischaemic events (including acute and subacute stent thrombosis (ST), myocardial infarction (MI), and urgent revascularization).
Danish: Den kliniske fordel af de mere potente P2Y12-hæmmere ticagrelor og prasugrel er i deres pivotale studier relateret til en signifikant reduktion af tilbagevendende iskæmiske hændelser (inklusive akut og subakut stenttrombose (ST), myokardieinfarkt (MI) og akut revaskularisering).
English: In a randomised, double-blind, parallel-group study (CLARINET), 906 paediatric patients (neonates and infants) with cyanotic congenital heart disease palliated with a systemic-to-pulmonary arterial shunt were randomised to receive clopidogrel 0.2 mg/kg (n=467) or placebo (n=439) along with concomitant background therapy up to the time of second stage surgery.
Danish: I et randomiseret, dobbelblindt, parallelgruppestudie (CLARINET) blev 906 pædiatriske patienter (nyfødte og spædbørn) med cyanotisk kongenit hjertesygdom palliativt opereret med en systemisk-til-pulmonalarterie shunt randomiseret til at få clopidogrel 0,2 mg/kg (n=467) eller placebo (=439) med samtidig standardbehandling indtil tidspunktet for 2. stadie-kirurgi.
English: Thrombolytics: the safety of the concomitant administration of clopidogrel, fibrin or non-fibrin specific thrombolytic agents and heparins was assessed in patients with acute myocardial infarction.
Danish: Trombolytika: Sikkerheden ved samtidig administration af clopidogrel, fibrin eller non-fibrinspecifikke trombolytiske midler og hepariner blev bedømt hos patienter med AMI.
English: The use of clopidogrel in CURE was associated with a decrease in the need of thrombolytic therapy (RRR = 43.3%; CI: 24.3%, 57.5%) and GPIIb/IIIa inhibitors (RRR = 18.2%; CI: 6.5%, 28.3%).
Danish: I CURE var anvendelse af clopidogrel forbundet med et aftagende behov for behandling med trombolytika (RRR = 43,3 %, CI: 24,3 %, 57,5 %) og GPIIb/IIIa-hæmmere (RRR = 18,2 %, CI: 6,5 %, 28,3 %).
English: The efficacy of clopidogrel was observed independently of the dose of ASA (75-325 mg once daily).
Danish: Clopidogrels virkning blev observeret uden relation til doseringen af ASA (75325 mg en gang daglig).
English: • You should tell your doctor if a surgery (including dental) is planned.
Danish: Skal du fortælle din læge, at du er i behandling med Iscover, hvis du skal have foretaget en planlagt operation (også hos tandlægen).
English: The guided de-escalation did not result in an increased combined risk of ischemic events (2.5% in the de escalation group vs 3.2% in the control group; p non-inferiority=0.0115), nor in the key secondaryendpoint of BARC bleeding ≥2 ((5%) in the de-escalation group versus 6% in the control group (p=0.23)).
Danish: Den guidede de-eskalering resulterede ikke i en øget kombineret risiko for iskæmiske hændelser (2,5% i deeskaleringsgruppen mod 3,2% i kontrolgruppen, p non-inferioritet = 0,0115), heller ikke i det centrale sekundære endepunkt for BARC ≥2 blødning ((5%) i de-eskaleringsgruppen mod 6% i kontrolgruppen (p = 0,23)).
English: The dose of 0.2 mg/kg achieved the mean percent inhibition of 49.3% (5 µM ADP-induced platelet aggregation) which was comparable to that of adults taking Iscover 75 mg/day.
Danish: En dosis på 0,2 mg/kg opnåede en gennemsnitlig procentvis hæmning på 49,3 % (5 µM ADP-induceret trombocytaggregation), hvilket er sammenligneligt med voksne, der tager Iscover 75 mg/dag.
English: CYP2C19 is involved in the formation of both the active metabolite and the 2-oxo-clopidogrel intermediate metabolite.
Danish: CYP2C19 er involveret i dannelsen af såvel den aktive metabolit, som mellemstadiemetabolitten 2-oxoclopidogrel.
English: If you stop taking Iscover Do not stop the treatment unless your doctor tells you so.
Danish: Du må ikke ophøre med behandlingen, medmindre din læge fortæller dig, at du skal gøre det.
English: PVC/PVDC/Aluminium blisters or all aluminium blisters in cardboard cartons containing 7, 14, 28, 30, 84, 90 and 100 film-coated tablets.
Danish: Blisterkort af PVC/PVDC/aluminium eller aluminium i kartonæsker der indeholder 7, 14, 28, 30, 50, 84, 90 og 100 filmovertrukne tabletter.
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Iscover in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Danish: Hvis du har haft alvorlige smerter i brystet (hjertekrampe (ustabil angina pectoris) eller hjerteanfald), kan din læge ordinere Iscover i kombination med acetylsalicylsyre, som er et stof, der indgår i mange typer medicin til smertelindring og febersænkning.
English: It also contains: hydrogenated castor oil and lactose.
Danish: Indeholder også: lactose og hydrogeneret ricinusolie.